|
|
|
|
||
Re: Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance“Based upon preliminary estimates, cash, cash equivalents and investments totaled $157.4 million at December 31, 2019. Calithera expects to utilize cash and investments between $75 and $85 million in 2020.” So, a secondary offering in the second half of 2020 will probably be needed |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
2747 | Re: Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance | JoeFlow | 5 | 1/18/2020 11:05:40 AM |